|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 93 No. 5 (March 1), 1999:
pp. 1496-1501
RAPID COMMUNICATION
Susceptibility to Childhood Acute Lymphoblastic Leukemia: Influence
of CYP1A1, CYP2D6, GSTM1, and GSTT1 Genetic Polymorphisms
Maja Krajinovic,
Damian Labuda,
Chantal Richer,
Sepideh Karimi, and
Daniel Sinnett
From Service d'Hématologie-Oncologie, Centre de
Cancérologie Charles-Bruneau et Centre de Recherche,
Hôpital Sainte-Justine; and Département de Pédiatrie,
Université de Montréal, Montréal, Quebec, Canada.
Although acute lymphoblastic leukemia (ALL) is the most common
childhood cancer, factors governing susceptibility to this disease have
not yet been identified. As such, ALL offers a useful opportunity to
examine the glutathione S-transferase and cytochrome P450 genes in
determining susceptibility to pediatric cancers. Both enzymes are
involved in carcinogen metabolism and have been shown to influence the
risk a variety of solid tumors in adults. To determine whether these
genes played a similar role in childhood leukemogenesis, we compared
the allele frequencies of 177 childhood ALL patients and 304 controls
for the CYP1A1, CYP2D6, GSTM1, and GSTT1 genes. We chose the French
population of Quebec as our study population because of its relative
genetic homogeneity. The GSTM1 null and CYP1A1*2A genotypes were both
found to be significant predictors of ALL risk (odds ratio
[OR] = 1.8). Those possessing both genotypes were at an even
greater risk of developing the disease (OR = 3.3). None of the
other alleles tested for proved to be significant indicators of ALL
risk. Unexpectedly, girls carrying the CYP1A1*4 were significantly
underrepresented in the ALL group (OR = 0.2), suggesting that a
gender-specific protective role exists for this allele. These results
suggest that the risk of ALL may indeed be associated with
xenobiotics-metabolism, and thus with environmental exposures. Our
findings may also explain, in part, why ALL is more prevalent among
males than females.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. P. Chokkalingam and P. A. Buffler
Genetic susceptibility to childhood leukaemia
Radiat Prot Dosimetry,
December 1, 2008;
132(2):
119 - 129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Bolufer, M. Collado, E. Barragan, J. Cervera, M.-J. Calasanz, D. Colomer, J. Roman-Gomez, and M. A. Sanz
The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia
Haematologica,
March 1, 2007;
92(3):
308 - 314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Healy, H. Belanger, P. Beaulieu, M. Lariviere, D. Labuda, and D. Sinnett
Promoter SNPs in G1/S checkpoint regulators and their impact on the susceptibility to childhood leukemia
Blood,
January 15, 2007;
109(2):
683 - 692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Vigano, E. Somigliana, I. Chiodo, A. Abbiati, and P. Vercellini
Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis
Hum. Reprod. Update,
January 1, 2006;
12(1):
77 - 89.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. F. Masson, L. Sharp, S. C. Cotton, and J. Little
Cytochrome P-450 1A1 Gene Polymorphisms and Risk of Breast Cancer: A HuGE Review
Am. J. Epidemiol.,
May 15, 2005;
161(10):
901 - 915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Selvin
Cytochrome P450 1A1 Polymorphism and Childhood Leukemia: An Analysis of Matched Pairs Case-Control Genotype Data
Cancer Epidemiol. Biomarkers Prev.,
August 1, 2004;
13(8):
1371 - 1374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L'Ecuyer, Z. Allebban, R. Thomas, and R. Vander Heide
Glutathione S-transferase overexpression protects against anthracycline-induced H9C2 cell death
Am J Physiol Heart Circ Physiol,
June 1, 2004;
286(6):
H2057 - H2064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Pui, M. V. Relling, and J. R. Downing
Acute Lymphoblastic Leukemia
N. Engl. J. Med.,
April 8, 2004;
350(15):
1535 - 1548.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Barnette, R. Scholl, M. Blandford, L. Ballard, A. Tsodikov, J. Magee, S. Williams, M. Robertson, F. Ali-Osman, R. Lemons, et al.
High-Throughput Detection of Glutathione S-Transferase Polymorphic Alleles in a Pediatric Cancer Population
Cancer Epidemiol. Biomarkers Prev.,
February 1, 2004;
13(2):
304 - 313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Krajinovic, S. Lamothe, D. Labuda, E. Lemieux-Blanchard, Y. Theoret, A. Moghrabi, and D. Sinnett
Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia
Blood,
January 1, 2004;
103(1):
252 - 257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hohaus, G. Massini, F. D'Alo', F. Guidi, R. Putzulu, A. Scardocci, A. Rabi, A. L. Di Febo, M. T. Voso, and G. Leone
Association between Glutathione S-Transferase Genotypes and Hodgkin's Lymphoma Risk and Prognosis
Clin. Cancer Res.,
August 1, 2003;
9(9):
3435 - 3440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Voso, F. D'Alo', R. Putzulu, L. Mele, A. Scardocci, P. Chiusolo, R. Latagliata, F. Lo-Coco, S. Rutella, L. Pagano, et al.
Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia
Blood,
September 26, 2002;
100(8):
2703 - 2707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Davies, S. Bhatia, J. A. Ross, W. R. Kiffmeyer, P. S. Gaynon, G. A. Radloff, L. L. Robison, and J. P. Perentesis
Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia
Blood,
June 17, 2002;
100(1):
67 - 71.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Krajinovic, D. Labuda, G. Mathonnet, M. Labuda, A. Moghrabi, J. Champagne, and D. Sinnett
Polymorphisms in Genes Encoding Drugs and Xenobiotic Metabolizing Enzymes, DNA Repair Enzymes, and Response to Treatment of Childhood Acute Lymphoblastic Leukemia
Clin. Cancer Res.,
March 1, 2002;
8(3):
802 - 810.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Loffler, J. Bergmann, A. Hochhaus, R. Hehlmann, A. Kramer, and the German CML Study Group
Reduced risk for chronic myelogenous leukemia in individuals with the cytochrome P-450 gene polymorphism CYP1A1*2A
Blood,
December 15, 2001;
98(13):
3874 - 3875.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Garte
Metabolic Susceptibility Genes As Cancer Risk Factors: Time for a Reassessment?
Cancer Epidemiol. Biomarkers Prev.,
December 1, 2001;
10(12):
1233 - 1237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Garte, L. Gaspari, A.-K. Alexandrie, C. Ambrosone, H. Autrup, J. L. Autrup, H. Baranova, L. Bathum, S. Benhamou, P. Boffetta, et al.
Metabolic Gene Polymorphism Frequencies in Control Populations
Cancer Epidemiol. Biomarkers Prev.,
December 1, 2001;
10(12):
1239 - 1248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.M. Hadfield, S. Manek, D.E. Weeks, H.J. Mardon, D.H. Barlow, and S.H. Kennedy
Linkage and association studies of the relationship between endometriosis and genes encoding the detoxification enzymes GSTM1, GSTT1 and CYP1A1
Mol. Hum. Reprod.,
November 1, 2001;
7(11):
1073 - 1078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sarmanova, K. Benesova, I. Gut, V. Nedelcheva-Kristensen, L. Tynkova, and P. Soucek
Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas
Hum. Mol. Genet.,
June 1, 2001;
10(12):
1265 - 1273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Tsukasaki, C. W. Miller, T. Kubota, S. Takeuchi, T. Fujimoto, S. Ikeda, M. Tomonaga, and H. P. Koeffler
Tumor Necrosis Factor {{alpha}} Polymorphism Associated with Increased Susceptibility to Development of Adult T-Cell Leukemia/Lymphoma in Human T-lymphotropic Virus Type 1 Carriers
Cancer Res.,
May 1, 2001;
61(9):
3770 - 3774.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Krajinovic, C. Richer, H. Sinnett, D. Labuda, and D. Sinnett
Genetic Polymorphisms of N-Acetyltransferases 1 and 2 and Gene-Gene Interaction in the Susceptibility to Childhood Acute Lymphoblastic Leukemia
Cancer Epidemiol. Biomarkers Prev.,
June 1, 2000;
9(6):
557 - 562.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. M. Davies, L. L. Robison, J. D. Buckley, G. A. Radloff, J. A. Ross, and J. P. Perentesis
Glutathione S-Transferase Polymorphisms in Children with Myeloid Leukemia: A Children's Cancer Group Study
Cancer Epidemiol. Biomarkers Prev.,
June 1, 2000;
9(6):
563 - 566.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. L. Wiemels, A. Pagnamenta, G. M. Taylor, O. B. Eden, F. E. Alexander, and M. F. Greaves
A Lack of a Functional NAD(P)H:Quinone Oxidoreductase Allele Is Selectively Associated with Pediatric Leukemias That Have MLL Fusions
Cancer Res.,
August 1, 1999;
59(16):
4095 - 4099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Salomon-Nguyen, V. Della-Valle, M. Mauchauffe, M. Busson-Le Coniat, J. Ghysdael, R. Berger, and O. A. Bernard
The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion
PNAS,
June 6, 2000;
97(12):
6757 - 6762.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|